Seeking Brain Biomarkers for Preventive Therapy in Huntington Disease

Distinct Brain Volume Changes Correlating with Clinical Stage, Disease Progression Rate, Mutation Size, and Age at Onset Prediction as Early Biomarkers of Brain Atrophy in Huntington's Disease

(2009) Ferdinando Squitieri et al.   CNS Neuroscience & Therapeutics

Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins

(2009) Ferdinando Squitieri et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Longitudinal diffusion tensor imaging in Huntington's Disease

(2009) Kurt E. Weaver et al.   EXPERIMENTAL NEUROLOGY

Relationship between CAG repeat length and brain volume in premanifest and early Huntington’s disease

(2009) S. M. D. Henley et al.   JOURNAL OF NEUROLOGY

Abnormal motor cortex plasticity in premanifest and very early manifest Huntington disease

(2009) M. Orth et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data

(2009) Sarah J Tabrizi et al.   LANCET NEUROLOGY

Dopamine in Motor Cortex Is Necessary for Skill Learning and Synaptic Plasticity

(2009) Katiuska Molina-Luna et al.   PLoS One

Hypothalamic involvement in Huntington's disease: an in vivo PET study

(2008) M. Politis et al.   BRAIN

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity

(2008) H. D. Rosas et al.   BRAIN

Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease

(2008) India Bohanna et al.   BRAIN RESEARCH REVIEWS

Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington’s disease

(2008) J.C.H. van Oostrom et al.   EUROPEAN JOURNAL OF NEUROLOGY

Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II

(2008) Alexandra Benchoua et al.   HUMAN MOLECULAR GENETICS

Molecular medicine: predicting and preventing Huntington’s disease

(2008) Ferdinando Squitieri et al.   NEUROLOGICAL SCIENCES

fMRI reveals altered auditory processing in manifest and premanifest Huntington's disease

(2008) Carsten Saft et al.   NEUROPSYCHOLOGIA

Interaction between N-methyl-d-aspartic acid receptors and D1 dopamine receptors: An important mechanism for brain plasticity

(2008) L. Scott et al.   NEUROSCIENCE

Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat

(2007) H H Ruocco et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY